When available, information regarding genotype, the timing of menses/amenorrhea, the use of HRT and labs including gal-1P, FSH, anti-Müllerian hormone (AMH), luteinizing hormone (LH) and estradiol were recorded longitudinally for each patient. This evidence concerns the gene BRD2 and amenorrhea.